JP2000505447A5 - - Google Patents

Download PDF

Info

Publication number
JP2000505447A5
JP2000505447A5 JP1997529493A JP52949397A JP2000505447A5 JP 2000505447 A5 JP2000505447 A5 JP 2000505447A5 JP 1997529493 A JP1997529493 A JP 1997529493A JP 52949397 A JP52949397 A JP 52949397A JP 2000505447 A5 JP2000505447 A5 JP 2000505447A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997529493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000505447A (ja
Filing date
Publication date
Priority claimed from US08/604,463 external-priority patent/US6423694B1/en
Application filed filed Critical
Publication of JP2000505447A publication Critical patent/JP2000505447A/ja
Publication of JP2000505447A5 publication Critical patent/JP2000505447A5/ja
Ceased legal-status Critical Current

Links

JP9529493A 1996-02-21 1997-02-14 ウリジン三リン酸及び関連化合物で中耳炎を治療する方法 Ceased JP2000505447A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/604,463 1996-02-21
US08/604,463 US6423694B1 (en) 1996-02-21 1996-02-21 Method of treating otitis media with uridine triphosphates and related compounds
PCT/US1997/002299 WO1997029756A1 (en) 1996-02-21 1997-02-14 Method of treating otitis media with uridine triphosphates and related compounds

Publications (2)

Publication Number Publication Date
JP2000505447A JP2000505447A (ja) 2000-05-09
JP2000505447A5 true JP2000505447A5 (Direct) 2004-11-25

Family

ID=24419702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9529493A Ceased JP2000505447A (ja) 1996-02-21 1997-02-14 ウリジン三リン酸及び関連化合物で中耳炎を治療する方法

Country Status (11)

Country Link
US (1) US6423694B1 (Direct)
EP (1) EP0897301B1 (Direct)
JP (1) JP2000505447A (Direct)
KR (1) KR19990082562A (Direct)
CN (1) CN1211186A (Direct)
AT (1) ATE225663T1 (Direct)
AU (1) AU730888B2 (Direct)
CA (1) CA2246581A1 (Direct)
DE (1) DE69716255T2 (Direct)
NZ (1) NZ331446A (Direct)
WO (1) WO1997029756A1 (Direct)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250188C (en) * 1996-03-27 2008-12-09 Inspire Pharmaceuticals, Inc. Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
US6673779B2 (en) * 1996-03-27 2004-01-06 Inspire Pharmaceuticals, Inc. Method of treating ciliary dyskinesia with dinucleoside polyphosphate compounds or UTP analogues
US6420347B1 (en) 1997-03-27 2002-07-16 Inspire Pharmaceuticals, Inc. Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5968913A (en) * 1996-07-03 1999-10-19 Inspire Pharmaceuticals, Inc. Pharmaceutical compositions of uridine triphosphate
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
US6462028B2 (en) 1997-07-25 2002-10-08 Inspire Pharmaceuticals, Inc. Method of promoting cervical and vaginal secretions
DK1012154T3 (da) * 1997-07-25 2004-07-26 Inspire Pharmaceuticals Inc Salte af di(uridin-5'-tetraphosphat), fremgangsmåde til fremstilling og anvendelser deraf
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
CN100354296C (zh) * 1998-10-02 2007-12-12 雅玛山酱油株式会社 二尿苷四磷酸或其盐的晶体和其制备方法、以及制备该化合物的方法
JP3247685B2 (ja) * 1998-10-02 2002-01-21 ヤマサ醤油株式会社 ジウリジンテトラホスフェート又はその塩の結晶及びその製造法、並びに該化合物の製造法
US6645532B1 (en) * 1999-01-19 2003-11-11 Matthew Lutin Compositions and method for relieving discomfort in the ears
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US7109181B2 (en) 2001-06-25 2006-09-19 Inspire Pharmaceuticals, Inc. Joint lubrication with P2Y purinergic receptor agonists
US7256183B2 (en) 2001-11-06 2007-08-14 Inspire Pharmaceuticals, Inc. Method for treating or preventing inflammatory diseases
WO2004037167A2 (en) * 2002-10-18 2004-05-06 Molichem Medicines, Inc. Methods of treating dry eye disease with lantibiotics
WO2005115432A2 (en) * 2004-05-06 2005-12-08 Molichem Medicines, Inc. Treatment of ocular diseases and disorders using lantibiotic compositions
EP1750740A4 (en) * 2004-05-06 2009-06-10 Molichem Medicines Inc TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING COMPOSITIONS CONTAINING LANTIBIOTICS
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
WO2007100790A2 (en) 2006-02-27 2007-09-07 Ahm Technologies, Inc. Eustachian tube device and method
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
JP2011524367A (ja) 2008-06-12 2011-09-01 メドトロニック・ゾーメド・インコーポレーテッド 慢性の創傷を治療するための方法
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
JP6463629B2 (ja) 2011-05-10 2019-02-06 ネクスト サイエンス アイピー ホールディングス ピーティワイ エルティーディ 抗菌性固体およびその製造方法
HU227743B1 (en) * 2011-07-22 2012-02-28 Debreceni Egyetem Eardrop composition and process for producing this

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260073A (en) * 1990-05-21 1993-11-09 Norwich Eaton Pharmaceuticals, Inc. Use of phenylpropanolamine as a mucus secretogogue in the upper airways
GB9027968D0 (en) * 1990-12-22 1991-02-13 Fisons Plc Method of treatment
FR2677250B1 (fr) * 1991-06-05 1995-01-20 Synthelabo Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
EP0517573A1 (fr) * 1991-06-05 1992-12-09 Synthelabo Compositions pharmaceutiques pour le traitement des affections des voies respiratoires
FR2684299B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US5789391A (en) * 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds

Similar Documents

Publication Publication Date Title
JP2000502280A5 (Direct)
JP2000501771A5 (Direct)
JP2000501599A5 (Direct)
JP2000501018A5 (Direct)
JP2000500076A5 (Direct)
JP2000501324A5 (Direct)
JP2000502472A5 (Direct)
JP2000501338A5 (Direct)
JP2000501825A5 (Direct)
JP2000500874A5 (Direct)
JP2000502425A5 (Direct)
JP2000502485A5 (Direct)
JP2000502568A5 (Direct)
JP2000501774A5 (Direct)
JP2000500912A5 (Direct)
JP2000502570A5 (Direct)
JP2001527517A5 (Direct)
JP2000508259A5 (Direct)
JP2000501876A5 (Direct)
JP2000501744A5 (Direct)
JP2000501229A5 (Direct)
JP2000502316A5 (Direct)
JP2000500857A5 (Direct)
JP2000502714A5 (Direct)
JP2000501569A5 (Direct)